PAMS
INO icon

Pictet Asset Management (Switzerland)’s Inovio Pharmaceuticals INO Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,292
Closed -$32.4K – 1985
2023
Q1 		$32.4K Hold
3,292
– – ﹤0.01% 1958
2022
Q4 		$62K Buy
3,292
+2,011
+157% +$45.6K ﹤0.01% 1945
2022
Q3 		$27K Hold
1,281
– – ﹤0.01% 1550
2022
Q2 		$27K Hold
1,281
– – ﹤0.01% 1559
2022
Q1 		$55K Hold
1,281
– – ﹤0.01% 1650
2021
Q4 		$77K Sell
1,281
-27
-2% -$2.16K ﹤0.01% 1671
2021
Q3 		$112K Buy
+1,308
New +$131K ﹤0.01% 1673

Other funds holding INO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s INO Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) sold out of Inovio Pharmaceuticals (INO) in Q2 2023, closing a stake of 3,292 shares — an estimated $32.4K sold.

Pictet Asset Management (Switzerland) first reported a position in INO in Q3 2021 and held it in 7 quarters. The position peaked at $112K in Q3 2021. 133 funds tracked by Wall St. Rank hold INO as of Q2 2023.

  • Pictet Asset Management (Switzerland) reported no remaining Inovio Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 3,292 Inovio Pharmaceuticals shares in Q2 2023, an estimated $32.4K.
  • Pictet Asset Management (Switzerland) first reported a position in Inovio Pharmaceuticals in Q3 2021 and held it in 7 quarters.
  • Pictet Asset Management (Switzerland)'s Inovio Pharmaceuticals position peaked at $112K in Q3 2021.
  • 133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.